Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 52

Cited In for PubMed (Select 16449666)

1.

HDAC1 controls CD8+ T cell homeostasis and antiviral response.

Tschismarov R, Firner S, Gil-Cruz C, Göschl L, Boucheron N, Steiner G, Matthias P, Seiser C, Ludewig B, Ellmeier W.

PLoS One. 2014 Oct 21;9(10):e110576. doi: 10.1371/journal.pone.0110576. eCollection 2014.

2.

Quantitative phosphoproteomics of cytotoxic T cells to reveal protein kinase d 2 regulated networks.

Navarro MN, Goebel J, Hukelmann JL, Cantrell DA.

Mol Cell Proteomics. 2014 Dec;13(12):3544-57. doi: 10.1074/mcp.M113.037242. Epub 2014 Sep 29.

3.

Protein kinase D3 is essential for prostratin-activated transcription of integrated HIV-1 provirus promoter via NF-κB signaling pathway.

Wang H, Zhu X, Zhu Y, Liu J, Hu X, Wang Y, Peng S, Chen Y, Chen R, Ding F, Liu R.

Biomed Res Int. 2014;2014:968027. doi: 10.1155/2014/968027. Epub 2014 Jul 21.

4.

Protein kinase D1 (PKD1) phosphorylation promotes dopaminergic neuronal survival during 6-OHDA-induced oxidative stress.

Asaithambi A, Ay M, Jin H, Gosh A, Anantharam V, Kanthasamy A, Kanthasamy AG.

PLoS One. 2014 May 7;9(5):e96947. doi: 10.1371/journal.pone.0096947. eCollection 2014.

5.

Protein kinase D1 mediates class IIa histone deacetylase phosphorylation and nuclear extrusion in intestinal epithelial cells: role in mitogenic signaling.

Sinnett-Smith J, Ni Y, Wang J, Ming M, Young SH, Rozengurt E.

Am J Physiol Cell Physiol. 2014 May 15;306(10):C961-71. doi: 10.1152/ajpcell.00048.2014. Epub 2014 Mar 19.

6.

Regulation of the latent-lytic switch in Epstein-Barr virus.

Kenney SC, Mertz JE.

Semin Cancer Biol. 2014 Jun;26:60-8. doi: 10.1016/j.semcancer.2014.01.002. Epub 2014 Jan 20. Review.

PMID:
24457012
7.

Protein kinase D promotes in vitro osteoclast differentiation and fusion.

Mansky KC, Jensen ED, Davidova J, Yamamoto M, Gopalakrishnan R.

J Biol Chem. 2013 Apr 5;288(14):9826-34. doi: 10.1074/jbc.M112.444133. Epub 2013 Feb 21.

8.

Phosphorylation of SET protein at Ser171 by protein kinase D2 diminishes its inhibitory effect on protein phosphatase 2A.

Irie A, Harada K, Araki N, Nishimura Y.

PLoS One. 2012;7(12):e51242. doi: 10.1371/journal.pone.0051242. Epub 2012 Dec 14.

9.

PKD2 and PKD3 promote prostate cancer cell invasion by modulating NF-κB- and HDAC1-mediated expression and activation of uPA.

Zou Z, Zeng F, Xu W, Wang C, Ke Z, Wang QJ, Deng F.

J Cell Sci. 2012 Oct 15;125(Pt 20):4800-11. doi: 10.1242/jcs.106542. Epub 2012 Jul 13.

10.

Rapid protein kinase D1 signaling promotes migration of intestinal epithelial cells.

Young SH, Rozengurt N, Sinnett-Smith J, Rozengurt E.

Am J Physiol Gastrointest Liver Physiol. 2012 Aug 1;303(3):G356-66. doi: 10.1152/ajpgi.00025.2012. Epub 2012 May 17.

11.

Protein kinase D isoforms are dispensable for integrin-mediated lymphocyte adhesion and homing to lymphoid tissues.

Matthews SA, San Lek H, Morrison VL, Mackenzie MG, Zarrouk M, Cantrell D, Fagerholm SC.

Eur J Immunol. 2012 May;42(5):1316-26. doi: 10.1002/eji.201142004.

12.

Design, Synthesis, and Biological Evaluation of PKD Inhibitors.

George KM, Frantz MC, Bravo-Altamirano K, Lavalle CR, Tandon M, Leimgruber S, Sharlow ER, Lazo JS, Wang QJ, Wipf P.

Pharmaceutics. 2011;3(2):186-228. doi: 10.3390/pharmaceutics3020186.

13.

Defect of adaptation to hypoxia in patients with COPD due to reduction of histone deacetylase 7.

To M, Yamamura S, Akashi K, Charron CE, Barnes PJ, Ito K.

Chest. 2012 May;141(5):1233-42. doi: 10.1378/chest.11-1536. Epub 2011 Dec 15.

14.

Protein kinase D3 is a pivotal activator of pathological cardiac hypertrophy by selectively increasing the expression of hypertrophic transcription factors.

Li C, Li J, Cai X, Sun H, Jiao J, Bai T, Zhou XW, Chen X, Gill DL, Tang XD.

J Biol Chem. 2011 Nov 25;286(47):40782-91. doi: 10.1074/jbc.M111.263046. Epub 2011 Oct 4.

15.

Protein kinase D controls voluntary-running-induced skeletal muscle remodelling.

Ellwanger K, Kienzle C, Lutz S, Jin ZG, Wiekowski MT, Pfizenmaier K, Hausser A.

Biochem J. 2011 Dec 15;440(3):327-4. doi: 10.1042/BJ20101980.

16.

Protein kinase D2 is a novel regulator of glioblastoma growth and tumor formation.

Azoitei N, Kleger A, Schoo N, Thal DR, Brunner C, Pusapati GV, Filatova A, Genze F, Möller P, Acker T, Kuefer R, Van Lint J, Baust H, Adler G, Seufferlein T.

Neuro Oncol. 2011 Jul;13(7):710-24. doi: 10.1093/neuonc/nor084.

17.

Protein kinase D1 (PKD1) activation mediates a compensatory protective response during early stages of oxidative stress-induced neuronal degeneration.

Asaithambi A, Kanthasamy A, Saminathan H, Anantharam V, Kanthasamy AG.

Mol Neurodegener. 2011 Jun 22;6:43. doi: 10.1186/1750-1326-6-43.

18.

Class IIa HDACs: from important roles in differentiation to possible implications in tumourigenesis.

Clocchiatti A, Florean C, Brancolini C.

J Cell Mol Med. 2011 Sep;15(9):1833-46. doi: 10.1111/j.1582-4934.2011.01321.x. Review.

19.

The coordination of T-cell function by serine/threonine kinases.

Finlay D, Cantrell D.

Cold Spring Harb Perspect Biol. 2011 Jan 1;3(1):a002261. doi: 10.1101/cshperspect.a002261.

20.

Phosphoproteomic analysis reveals an intrinsic pathway for the regulation of histone deacetylase 7 that controls the function of cytotoxic T lymphocytes.

Navarro MN, Goebel J, Feijoo-Carnero C, Morrice N, Cantrell DA.

Nat Immunol. 2011 Apr;12(4):352-61. doi: 10.1038/ni.2008. Epub 2011 Mar 13.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk